Fifty-six patients with chronic allergic rhinitis were selected for a randomized double-blind study comparing oxatomide with a placebo. At the end of the 1-month treatment period symptoms had disappeared or were markedly improved in 81% of the oxatomide-treated patients compared with only 17% of the placebo group. Therapeutic control was achieved in most patients with a dose of 30 mg bid. Improvements were characterized by a reduction in the number, duration and severity of episodes of rhinitis. Oxatomide also significantly reduced the requirements of patients for additional antiallergic medication. No significant side effects were reported.
Get full access to this article
View all access options for this article.
References
1.
EmanuelMBTowseGDW. Oxatomide a new drug combining anti-allergic and anti-spasmogenic properties. Drugs of Today1980, in press.
2.
De CreeJHörigChVerhaegenH. Oxatomide, a new antiallergic drug, in the treatment of various allergic diseases. Cur Med Res Opin1980; 6: 380–5.
3.
AwoutersFNiemegeersCJEVan den BerkJ. Oxatomide, a new orally active drug which inhibits both the release and the effects of allergic mediators. Experienta1977; 33: 1657–9.
4.
BorgersMDe BrabanderMVan ReemptsJAwoutersFJanssenPAJ. Morphological evaluation of oxatomide, a new antiallergic drug, in guinea pig anaphylaxis. Int Arch Allergy Appl Immunol1978; 56; 507–16.
5.
Van NuetenJMXhonneuxRJanssenPAJ. Preliminary data on antiserotonin effects of oxatomide, a novel anti-allergic compound. Arch Int Pharmacodyn Ther1978; 232: 217–20.
6.
De BeuleRVannieuwenhuyseECallierJ. Double-blind placebo-controlled clinical evaluation of oxatomide (R 35 443), a novel potent anti-allergic drug in the treatment of hay fever. Acta Allergol1977; 32: 278–89.
7.
FerrièreA. Oxatomide in the treatment of hay fever: a double-blind comparison with diphenhydramine and a placebo. Janssen Research Products Information Service, Clinical Research Report No R 35 443/15 (August 1978).
8.
Van der BijlWJFCordierRvan DishoeckEADeProostWVannieuwenhuyseE. A double-blind comparison of oxatomide (R 35 443) and diphenhydramine in the treatment of hay fever. Laryngoscope1980; 90: 145–51.
